array:24 [
  "pii" => "S2173574317300382"
  "issn" => "21735743"
  "doi" => "10.1016/j.reumae.2016.07.005"
  "estado" => "S300"
  "fechaPublicacion" => "2017-11-01"
  "aid" => "951"
  "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología"
  "copyrightAnyo" => "2016"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Reumatol Clin. 2017;13:354-6"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 696
    "formatos" => array:3 [
      "EPUB" => 97
      "HTML" => 370
      "PDF" => 229
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1699258X16300869"
      "issn" => "1699258X"
      "doi" => "10.1016/j.reuma.2016.07.005"
      "estado" => "S300"
      "fechaPublicacion" => "2017-11-01"
      "aid" => "951"
      "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Reumatol Clin. 2017;13:354-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 5111
        "formatos" => array:3 [
          "EPUB" => 199
          "HTML" => 3674
          "PDF" => 1238
        ]
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Caso cl&#237;nico</span>"
        "titulo" => "Kala-azar en un paciente con artritis reumatoide tratada con metotrexato"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "354"
            "paginaFinal" => "356"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 675
                "Ancho" => 900
                "Tamanyo" => 143147
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">C&#233;lulas mononucleadas fagocitarias &#40;macr&#243;fagos&#41; que contiene abundantes inclusiones de formas parasitarias compatibles con leishmaniasis&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Delia Reina, Dacia Cerd&#224;, Elena G&#252;ell, Joaqu&#237;n Mart&#237;nez Montauti, Antonio Pineda, H&#232;ctor Corominas"
            "autores" => array:6 [
              0 => array:2 [
                "nombre" => "Delia"
                "apellidos" => "Reina"
              ]
              1 => array:2 [
                "nombre" => "Dacia"
                "apellidos" => "Cerd&#224;"
              ]
              2 => array:2 [
                "nombre" => "Elena"
                "apellidos" => "G&#252;ell"
              ]
              3 => array:2 [
                "nombre" => "Joaqu&#237;n"
                "apellidos" => "Mart&#237;nez Montauti"
              ]
              4 => array:2 [
                "nombre" => "Antonio"
                "apellidos" => "Pineda"
              ]
              5 => array:2 [
                "nombre" => "H&#232;ctor"
                "apellidos" => "Corominas"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2173574317300382"
          "doi" => "10.1016/j.reumae.2016.07.005"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574317300382?idApp=UINPBA00004M"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16300869?idApp=UINPBA00004M"
      "url" => "/1699258X/0000001300000006/v1_201710191241/S1699258X16300869/v1_201710191241/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S217357431730093X"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2016.07.010"
    "estado" => "S300"
    "fechaPublicacion" => "2017-11-01"
    "aid" => "953"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Reumatol Clin. 2017;13:357-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 620
      "formatos" => array:3 [
        "EPUB" => 75
        "HTML" => 378
        "PDF" => 167
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Images in Clinical Rheumatology</span>"
      "titulo" => "Granuloma Annular-like Lesions as a Manifestation of Eosinophilic Granulomatosis With Polyangiitis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "357"
          "paginaFinal" => "358"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Lesiones granuloma anular-<span class="elsevierStyleItalic">like</span> como manifestaci&#243;n cut&#225;nea de granulomatosis eosinof&#237;lica con poliangitis"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1047
              "Ancho" => 1400
              "Tamanyo" => 345426
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">&#40;A and C&#41; Circular&#44; skin-colored and erythematous plaques measuring 2&#8211;4<span class="elsevierStyleHsp" style=""></span>cm&#44; with a more infiltrated border and small scabs on the surface&#46; &#40;B&#41; Histiocytes interspersed with bundles of degenerated collagen accompanied by an inflammatory infiltrate with abundant eosinophils &#40;hematoxylin-eosin&#44; 20&#215;&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Bel&#233;n Lozano-Masdemont, Celia Horcajada-Reales, Laura G&#243;mez-Recuero Mu&#241;oz, Ver&#243;nica Parra-Blanco"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Bel&#233;n"
              "apellidos" => "Lozano-Masdemont"
            ]
            1 => array:2 [
              "nombre" => "Celia"
              "apellidos" => "Horcajada-Reales"
            ]
            2 => array:2 [
              "nombre" => "Laura"
              "apellidos" => "G&#243;mez-Recuero Mu&#241;oz"
            ]
            3 => array:2 [
              "nombre" => "Ver&#243;nica"
              "apellidos" => "Parra-Blanco"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1699258X16300882"
        "doi" => "10.1016/j.reuma.2016.07.007"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16300882?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357431730093X?idApp=UINPBA00004M"
    "url" => "/21735743/0000001300000006/v1_201710250854/S217357431730093X/v1_201710250854/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2173574317301326"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2016.06.006"
    "estado" => "S300"
    "fechaPublicacion" => "2017-11-01"
    "aid" => "943"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Reumatol Clin. 2017;13:352-3"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 477
      "formatos" => array:3 [
        "EPUB" => 55
        "HTML" => 293
        "PDF" => 129
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>"
      "titulo" => "Cherubism&#46; A case report"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "352"
          "paginaFinal" => "353"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Querubismo&#46; Discusi&#243;n de un caso"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 572
              "Ancho" => 990
              "Tamanyo" => 72309
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">3D-reconstruction of patient lesions&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Paolo Cariati, Fernando Monsalve Iglesias, Jos&#233; Fern&#225;ndez Sol&#237;s, Alfredo Valencia Laseca, Ildefonso Martinez Lara"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Paolo"
              "apellidos" => "Cariati"
            ]
            1 => array:2 [
              "nombre" => "Fernando"
              "apellidos" => "Monsalve Iglesias"
            ]
            2 => array:2 [
              "nombre" => "Jos&#233;"
              "apellidos" => "Fern&#225;ndez Sol&#237;s"
            ]
            3 => array:2 [
              "nombre" => "Alfredo"
              "apellidos" => "Valencia Laseca"
            ]
            4 => array:2 [
              "nombre" => "Ildefonso"
              "apellidos" => "Martinez Lara"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1699258X16300626"
        "doi" => "10.1016/j.reuma.2016.06.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X16300626?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574317301326?idApp=UINPBA00004M"
    "url" => "/21735743/0000001300000006/v1_201710250854/S2173574317301326/v1_201710250854/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>"
    "titulo" => "Visceral Leishmaniasis in a Rheumatoid Arthritis Patient Receiving Methotrexate"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "354"
        "paginaFinal" => "356"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Delia Reina, Dacia Cerd&#224;, Elena G&#252;ell, Joaqu&#237;n Mart&#237;nez Montauti, Antonio Pineda, H&#232;ctor Corominas"
        "autores" => array:6 [
          0 => array:4 [
            "nombre" => "Delia"
            "apellidos" => "Reina"
            "email" => array:1 [
              0 => "deliareinasanz&#64;gmail&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Dacia"
            "apellidos" => "Cerd&#224;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Elena"
            "apellidos" => "G&#252;ell"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Joaqu&#237;n"
            "apellidos" => "Mart&#237;nez Montauti"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Antonio"
            "apellidos" => "Pineda"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "H&#232;ctor"
            "apellidos" => "Corominas"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio de Reumatolog&#237;a&#44; Hospital Mois&#232;s Broggi&#44; Consorci Sanitari Integral&#44; Sant Joan Desp&#237;&#44; Barcelona&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Medicina Interna&#44; Hospital de Barcelona&#44; Barcelona&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Hematolog&#237;a&#44; Hospital de Barcelona&#44; Barcelona&#44; Spain"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Kala-azar en un paciente con artritis reumatoide tratada con metotrexato"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 675
            "Ancho" => 900
            "Tamanyo" => 143147
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Phagocytic mononuclear cells &#40;macrophages&#41; with abundant parasitic inclusions compatible with leishmaniasis&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The spectrum of the possible comorbidities associated with rheumatoid arthritis &#40;RA&#41; <span class="elsevierStyleItalic">per se</span> includes not only infections&#44; but those attributable to the use of the conventional treatment of those infections&#46; Their high incidence has been reported both for glucocorticoids and immunosuppressive agents&#44; and with the use of biological therapy &#40;BT&#41;&#46; Among the options&#44; the drug most widely utilized as first-line treatment is methotrexate &#40;MTX&#41;&#44; which enables a better control of the disease&#44; although it can be accompanied by serious adverse effects such as hematotoxicity&#44; which can develop in up to 15&#37; of RA patients&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">To this day&#44; the scope of reported opportunistic infections is very wide&#44; ranging from primary infection by <span class="elsevierStyleItalic">Nocardia</span> or <span class="elsevierStyleItalic">Pneumocystis carinii</span> and fungal infections by <span class="elsevierStyleItalic">Candida</span>&#44; <span class="elsevierStyleItalic">Aspergillus</span>&#44; <span class="elsevierStyleItalic">Cryptococcus</span> or <span class="elsevierStyleItalic">Histoplasma</span>&#44; to viral infections&#44; mainly by herpes zoster&#46; Surprisingly&#44; although it is documented&#44; there are few cases of <span class="elsevierStyleItalic">Leishmania</span> infection&#46;<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#8211;4</span></a> Given the low incidence of visceral leishmaniasis &#40;VL&#41; in the Mediterranean region&#44; there has been no recommendation for screening prior to initiating BT&#44; and periodical serological surveillance of these patients is proposed only if they live in areas in which the frequency is higher&#46;<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">5&#44;6</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Case Report</span><p id="par0015" class="elsevierStylePara elsevierViewall">The patient was a 64-year-old woman who had undergone bilateral hip arthroplasty&#44; and had been diagnosed with RA in 2002 because of polyarthritis&#44; which was symmetrical&#44; erosive and seropositive &#40;positive for rheumatoid factor and anti-cyclic citrullinated peptide&#41;&#46; She progressively developed asymmetrical arthritis&#44; which affected large and small joints&#46; As background therapy for her disease she received 15<span class="elsevierStyleHsp" style=""></span>mg&#47;week of oral MTX&#44; 5<span class="elsevierStyleHsp" style=""></span>mg&#47;week of folic acid&#44; indomethacin at 25<span class="elsevierStyleHsp" style=""></span>mg&#47;8<span class="elsevierStyleHsp" style=""></span>h and low-dose prednisone&#46; She had no significant epidemiological history&#46; In 2012&#44; she had begun to note considerable weakness&#44; with episodes of spiking fever&#46; At the time of the present evaluation&#44; it had started 2 months earlier and was accompanied by pancytopenia &#40;leukocytes&#58; 3200 &#91;lymphocytes&#58; 1100&#93;&#44; hemoglobin&#58; 9<span class="elsevierStyleHsp" style=""></span>g&#47;L&#44; platelets&#58; 91&#44;000&#41;&#44; observed in a routine analysis&#46; She was admitted to the hospital to be studied&#46; The physical examination revealed mucocutaneous pallor and there were no signs of lymphadenopathy&#44; and the review of systems produced no new findings&#46; Treatment with MTX was discontinued due to the suspicion of hematotoxicity&#46; Abdominal ultrasound and computed tomography of abdomen and chest established the presence of splenomegaly&#46; Serology for human immunodeficiency virus and hepatitis B and C viruses was negative&#44; and a bone marrow aspirate &#40;BMA&#41; confirmed marrow cellularity preservation&#44; and diffuse intra- and extracellular involvement of leishmaniasis &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; Once the diagnosis of VL had been established&#44; treatment with liposomal amphotericin B was begun at a dose of 3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg body weight until the patient had received 10 doses&#46; After 10 weeks&#44; she was afebrile and her blood count began to improve gradually until it was normal&#46; At the present time&#44; she is asymptomatic and is taking hydroxychloroquine&#44; and good clinical control has been achieved in the management of RA&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Discussion</span><p id="par0020" class="elsevierStylePara elsevierViewall">Rheumatoid arthritis patients can develop a wide range of associated extra-articular comorbidities&#59; of these&#44; hematological disorders and infections account for a high percentage of cases&#44; and&#44; thus&#44; the differential diagnosis is very extensive&#46; Check-ups and follow-up visits of patients with RA are employed to monitor the analytical profile&#8212;hematological and biochemical&#8212;in accordance with recommended clinical practice guidelines&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> The study of a single cytopenia or of pancytopenia should include the complications of the disease itself&#44; the associated drug toxicity and possible nosocomial infections&#59; in addition&#44; hematological conditions should also be ruled out&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Leishmaniasis is understood to be a set of syndromes caused by infection of the protozoan of the genus <span class="elsevierStyleItalic">Leishmania</span>&#44; which is widely extended in tropical regions&#44; whereas <span class="elsevierStyleItalic">L&#46; infantum</span> causes a disease that is endemic in the Mediterranean&#46; It has three clinical profiles&#58; cutaneous&#44; mucosal and visceral&#46; The latter can be fatal in the absence of treatment&#46; It is transmitted by the bite of the phlebotomine sandfly&#46; Depending on the <span class="elsevierStyleItalic">Leishmania</span> species&#44; the genus of the transmitting insect and the geographic region&#44; the main reservoirs are dogs&#44; rodents and persons&#46; The onset of VL can be silent or&#44; in contrast&#44; full-blown &#40;kala-azar&#41;&#44; with its characteristic pentad&#58; prolonged fever&#44; weight loss&#44; hepatosplenomegaly&#44; pancytopenia and hypergammaglobulinemia&#46; At some point&#44; the subclinical disease can become symptomatic in patients who receive immunosuppressive agents like glucocorticoids&#44; MTX or BT&#46; There are three ways to establish the diagnosis of leishmaniasis&#58; clinical&#44; parasitic and immunological&#46; The parasitological diagnosis should be confirmed by the observation of the protozoan in a tissue or smear&#46; Should there be any doubt about the diagnosis&#44; the BMA provides satisfactory results&#46; The differential diagnosis of full-blown VL should include malignant hematological and lymphatic disorders&#44; as well as infectious diseases like malaria&#46; At the present time&#44; the treatment of choice of VL in developed countries is liposomal amphotericin B&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">In a review of the literature&#44; it is noteworthy that there are fewer cases of patients with RA being treated with MTX than those receiving anti-tumor necrosis factor &#40;TNF&#41; agents who develop <span class="elsevierStyleItalic">Leishmania</span> infection&#46; We have yet to know why&#46; These patients do not seem to have any common factor predisposing them to infection&#46; Methotrexate reduces the cell immune response&#44; inhibits neutrophil chemotaxis and T-cell proliferation&#44; and has been related to the development of infections by opportunistic pathogens&#44; among which we find <span class="elsevierStyleItalic">Leishmania</span>&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Patients with RA being treated with MTX have a greater predisposition to develop VL than the general population&#44; possibly due to immunological changes related to the underlying disease and the treatment they receive&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Tumor necrosis factor is a cytokine involved in the immune-mediated response to infection&#44; especially against intracellular pathogens&#46; The use of anti-TNF drugs in RA is growing&#44; and their utility is clearly related to an increase in the number of opportunistic infections in these patients&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">The diagnosis of VL should be considered in patients when there is a suspicion of infection if they are receiving MTX to treat an inflammatory rheumatic disease and live in regions in which leishmaniasis is endemic&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">The importance of the early diagnosis&#44; established during the follow-up visits in relation to the underlying disease&#44; made it possible for us to detect VL in our patient&#46; The prompt initiation of a specific treatment is fundamental in order to improve the prognosis of a potentially serious disease&#46; With this in mind&#44; we must not forget that&#44; although uncommon&#44; leishmaniasis is endemic in the Mediterranean&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conclusion</span><p id="par0055" class="elsevierStylePara elsevierViewall">The current management of RA patients is very satisfactory&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a> Improvements in monitoring and the identification of new therapeutic targets have resulted in high survival rates&#46; The prognosis is likewise more favorable&#59; however&#44; the same therapies that&#44; on occasion&#44; lead to remission&#44; also have certain additional risks&#46;<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">9&#44;10</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">The present report describes an infectious process that developed in the course of RA&#44; partially due to the associated susceptibility to chronic inflammatory disease&#44; together with the added risk conferred by immunosuppressive therapies like MTX&#46; The study of comorbidities of RA should emphasize infections by the usual pathogens&#44; without overlooking those produced by uncommon opportunistic microorganisms like <span class="elsevierStyleItalic">Leishmania</span>&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Ethical Disclosures</span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Protection of human and animal subjects</span><p id="par0065" class="elsevierStylePara elsevierViewall">The authors declare that no experiments were performed on humans or animals for this study&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Confidentiality of data</span><p id="par0070" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Right to privacy and informed consent</span><p id="par0075" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article&#46;</p></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Conflicts of Interest</span><p id="par0080" class="elsevierStylePara elsevierViewall">The authors declare they have no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:11 [
        0 => array:3 [
          "identificador" => "xres930904"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec905651"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres930903"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec905652"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Case Report"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Discussion"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Conclusion"
        ]
        8 => array:3 [
          "identificador" => "sec0025"
          "titulo" => "Ethical Disclosures"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Protection of human and animal subjects"
            ]
            1 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Confidentiality of data"
            ]
            2 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Right to privacy and informed consent"
            ]
          ]
        ]
        9 => array:2 [
          "identificador" => "sec0045"
          "titulo" => "Conflicts of Interest"
        ]
        10 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2016-05-12"
    "fechaAceptado" => "2016-07-14"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec905651"
          "palabras" => array:3 [
            0 => "Kala-azar"
            1 => "Rheumatoid arthritis"
            2 => "Methotrexate"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec905652"
          "palabras" => array:3 [
            0 => "Kala-azar"
            1 => "Artritis reumatoide"
            2 => "Metotrexato"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Patients with rheumatoid arthritis &#40;RA&#41; treated with disease-modifying antirheumatic drugs are susceptible to severe infections such as leishmaniasis&#46; As <span class="elsevierStyleItalic">L&#46; infantum</span> is endemic in the Mediterranean region&#44; it is necessary to rule this infectious process out in any RA patient presenting with fever and pancytopenia&#46; An early diagnosis based on a high suspicion can prevent a fatal outcome&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Los pacientes con artritis reumatoide &#40;AR&#41; tratados con f&#225;rmacos modificadores del curso de la enfermedad est&#225;n expuestos a desarrollar infecciones potencialmente graves como la leishmaniasis&#46; <span class="elsevierStyleItalic">L&#46; infantum</span> es end&#233;mica en el Mediterr&#225;neo&#44; hecho que obliga ante un paciente con AR que presenta fiebre y pancitopenia&#44; a descartar este proceso&#46; Un diagn&#243;stico de sospecha precoz&#44; puede evitar un curso y pron&#243;stico fatal&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Reina D&#44; Cerd&#224; D&#44; G&#252;ell E&#44; Mart&#237;nez Montauti J&#44; Pineda A&#44; Corominas H&#46; Kala-azar en un paciente con artritis reumatoide tratada con metotrexato&#46; Reumatol Clin&#46; 2017&#59;13&#58;354&#8211;356&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 675
            "Ancho" => 900
            "Tamanyo" => 143147
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Phagocytic mononuclear cells &#40;macrophages&#41; with abundant parasitic inclusions compatible with leishmaniasis&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Toxicity of low dose methotrexate in rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M&#46;E&#46; Weinblatt"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2012"
                        "volumen" => "35"
                        "numero" => "Suppl&#46; 12"
                        "paginaInicial" => "S1985"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "G&#46;S&#46; Karagiannidis"
                            1 => "M&#46; Mantzourani"
                            2 => "J&#46; Meletis"
                            3 => "A&#46;N&#46; Anastasopoulou"
                            4 => "G&#46;A&#46;J&#46; Vaiopoulos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/RHU.0b013e31823f0089"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Clin Rheumatol"
                        "fecha" => "2012"
                        "volumen" => "18"
                        "paginaInicial" => "59"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22198490"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "I&#46; Venizelos"
                            1 => "Z&#46; Tatsiou"
                            2 => "T&#46;G&#46; Papathomas"
                            3 => "A&#46; Orazi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Int J Infect Dis"
                        "fecha" => "2009"
                        "volumen" => "13"
                        "paginaInicial" => "169"
                        "paginaFinal" => "172"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antitumour necrosis factor-induced visceral and cutaneous leishmaniasis&#58; case report and review of the literature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Catal&#224;"
                            1 => "E&#46; Ro&#233;"
                            2 => "J&#46; Dalmau"
                            3 => "V&#46; Pomar"
                            4 => "C&#46; Mu&#241;oz"
                            5 => "O&#46; Yelamos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000370238"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dermatology"
                        "fecha" => "2015"
                        "volumen" => "230"
                        "paginaInicial" => "204"
                        "paginaFinal" => "207"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25633623"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Leishmaniasis in rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46; Pizzorni"
                            1 => "M&#46;E&#46; Secchi"
                            2 => "M&#46; Cutolo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Reumatismo"
                        "fecha" => "2007"
                        "volumen" => "59"
                        "paginaInicial" => "235"
                        "paginaFinal" => "239"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17898884"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comorbidities in RA"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "K&#46; Michaud"
                            1 => "F&#46; Wolfe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.berh.2007.06.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Best Pract Res Clin Rheumatol"
                        "fecha" => "2007"
                        "volumen" => "21"
                        "paginaInicial" => "885"
                        "paginaFinal" => "906"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17870034"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "Available from&#58; <span class="elsevierStyleInterRef" id="intr0010" href="http://www.ser.es/">http&#58;&#47;&#47;www&#46;ser&#46;es</span> &#91;accessed 02&#46;05&#46;16&#93;"
                  "contribucion" => array:1 [
                    0 => array:1 [
                      "titulo" => "Actualizaci&#243;n de la Gu&#237;a de Pr&#225;ctica Cl&#237;nica para el Manejo de la Artritis Reumatoide en Espa&#241;a"
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:1 [
                        "fecha" => "December 2011"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;A&#46; Singh"
                            1 => "K&#46;G&#46; Saag"
                            2 => "S&#46;L&#46; Bridges Jr&#46;"
                            3 => "E&#46;A&#46; Akl"
                            4 => "R&#46;R&#46; Bannuru"
                            5 => "M&#46;C&#46; Sullivan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.39977"
                      "Revista" => array:7 [
                        "tituloSerie" => "Arthritis Rheumatol"
                        "fecha" => "2016"
                        "volumen" => "68"
                        "paginaInicial" => "1"
                        "paginaFinal" => "26"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27870508"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S016950021000231X"
                          "estado" => "S300"
                          "issn" => "01695002"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consenso SER sobre la gesti&#243;n de riesgo del tratamiento con terapias biol&#243;gicas en pacientes con enfermedades reum&#225;ticas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; G&#243;mez Reino"
                            1 => "E&#46; Loza"
                            2 => "J&#46;L&#46; Andreu"
                            3 => "A&#46; Balsa"
                            4 => "E&#46; Batlle"
                            5 => "J&#46;D&#46; Ca&#241;ete"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.reuma.2011.05.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Reumatol Clin"
                        "fecha" => "2011"
                        "volumen" => "7"
                        "paginaInicial" => "284"
                        "paginaFinal" => "298"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21925444"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "How to use biological agents in patients with rheumatoid arthritis who have comorbid disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;S&#46; Richards"
                            1 => "S&#46;M&#46; Dowell"
                            2 => "M&#46;E&#46; Quinones"
                            3 => "G&#46;S&#46; Kerr"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2015"
                        "volumen" => "17"
                        "paginaInicial" => "351"
                        "paginaFinal" => "3658"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000001300000006/v1_201710250854/S2173574317300382/v1_201710250854/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "43296"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case report"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001300000006/v1_201710250854/S2173574317300382/v1_201710250854/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574317300382?idApp=UINPBA00004M"
]
Share
Journal Information
Vol. 13. Issue 6.
Pages 354-356 (November - December 2017)
Visits
5482
Vol. 13. Issue 6.
Pages 354-356 (November - December 2017)
Case Report
Full text access
Visceral Leishmaniasis in a Rheumatoid Arthritis Patient Receiving Methotrexate
Kala-azar en un paciente con artritis reumatoide tratada con metotrexato
Visits
5482
Delia Reinaa,
Corresponding author
deliareinasanz@gmail.com

Corresponding author.
, Dacia Cerdàa, Elena Güellb, Joaquín Martínez Montautib, Antonio Pinedac, Hèctor Corominasa
a Servicio de Reumatología, Hospital Moisès Broggi, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain
b Servicio de Medicina Interna, Hospital de Barcelona, Barcelona, Spain
c Servicio de Hematología, Hospital de Barcelona, Barcelona, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Abstract

Patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic drugs are susceptible to severe infections such as leishmaniasis. As L. infantum is endemic in the Mediterranean region, it is necessary to rule this infectious process out in any RA patient presenting with fever and pancytopenia. An early diagnosis based on a high suspicion can prevent a fatal outcome.

Keywords:
Kala-azar
Rheumatoid arthritis
Methotrexate
Resumen

Los pacientes con artritis reumatoide (AR) tratados con fármacos modificadores del curso de la enfermedad están expuestos a desarrollar infecciones potencialmente graves como la leishmaniasis. L. infantum es endémica en el Mediterráneo, hecho que obliga ante un paciente con AR que presenta fiebre y pancitopenia, a descartar este proceso. Un diagnóstico de sospecha precoz, puede evitar un curso y pronóstico fatal.

Palabras clave:
Kala-azar
Artritis reumatoide
Metotrexato
Full Text
Introduction

The spectrum of the possible comorbidities associated with rheumatoid arthritis (RA) per se includes not only infections, but those attributable to the use of the conventional treatment of those infections. Their high incidence has been reported both for glucocorticoids and immunosuppressive agents, and with the use of biological therapy (BT). Among the options, the drug most widely utilized as first-line treatment is methotrexate (MTX), which enables a better control of the disease, although it can be accompanied by serious adverse effects such as hematotoxicity, which can develop in up to 15% of RA patients.1

To this day, the scope of reported opportunistic infections is very wide, ranging from primary infection by Nocardia or Pneumocystis carinii and fungal infections by Candida, Aspergillus, Cryptococcus or Histoplasma, to viral infections, mainly by herpes zoster. Surprisingly, although it is documented, there are few cases of Leishmania infection.2–4 Given the low incidence of visceral leishmaniasis (VL) in the Mediterranean region, there has been no recommendation for screening prior to initiating BT, and periodical serological surveillance of these patients is proposed only if they live in areas in which the frequency is higher.5,6

Case Report

The patient was a 64-year-old woman who had undergone bilateral hip arthroplasty, and had been diagnosed with RA in 2002 because of polyarthritis, which was symmetrical, erosive and seropositive (positive for rheumatoid factor and anti-cyclic citrullinated peptide). She progressively developed asymmetrical arthritis, which affected large and small joints. As background therapy for her disease she received 15mg/week of oral MTX, 5mg/week of folic acid, indomethacin at 25mg/8h and low-dose prednisone. She had no significant epidemiological history. In 2012, she had begun to note considerable weakness, with episodes of spiking fever. At the time of the present evaluation, it had started 2 months earlier and was accompanied by pancytopenia (leukocytes: 3200 [lymphocytes: 1100], hemoglobin: 9g/L, platelets: 91,000), observed in a routine analysis. She was admitted to the hospital to be studied. The physical examination revealed mucocutaneous pallor and there were no signs of lymphadenopathy, and the review of systems produced no new findings. Treatment with MTX was discontinued due to the suspicion of hematotoxicity. Abdominal ultrasound and computed tomography of abdomen and chest established the presence of splenomegaly. Serology for human immunodeficiency virus and hepatitis B and C viruses was negative, and a bone marrow aspirate (BMA) confirmed marrow cellularity preservation, and diffuse intra- and extracellular involvement of leishmaniasis (Fig. 1). Once the diagnosis of VL had been established, treatment with liposomal amphotericin B was begun at a dose of 3mg/kg body weight until the patient had received 10 doses. After 10 weeks, she was afebrile and her blood count began to improve gradually until it was normal. At the present time, she is asymptomatic and is taking hydroxychloroquine, and good clinical control has been achieved in the management of RA.

Fig. 1.

Phagocytic mononuclear cells (macrophages) with abundant parasitic inclusions compatible with leishmaniasis.

(0.14MB).
Discussion

Rheumatoid arthritis patients can develop a wide range of associated extra-articular comorbidities; of these, hematological disorders and infections account for a high percentage of cases, and, thus, the differential diagnosis is very extensive. Check-ups and follow-up visits of patients with RA are employed to monitor the analytical profile—hematological and biochemical—in accordance with recommended clinical practice guidelines.7 The study of a single cytopenia or of pancytopenia should include the complications of the disease itself, the associated drug toxicity and possible nosocomial infections; in addition, hematological conditions should also be ruled out.

Leishmaniasis is understood to be a set of syndromes caused by infection of the protozoan of the genus Leishmania, which is widely extended in tropical regions, whereas L. infantum causes a disease that is endemic in the Mediterranean. It has three clinical profiles: cutaneous, mucosal and visceral. The latter can be fatal in the absence of treatment. It is transmitted by the bite of the phlebotomine sandfly. Depending on the Leishmania species, the genus of the transmitting insect and the geographic region, the main reservoirs are dogs, rodents and persons. The onset of VL can be silent or, in contrast, full-blown (kala-azar), with its characteristic pentad: prolonged fever, weight loss, hepatosplenomegaly, pancytopenia and hypergammaglobulinemia. At some point, the subclinical disease can become symptomatic in patients who receive immunosuppressive agents like glucocorticoids, MTX or BT. There are three ways to establish the diagnosis of leishmaniasis: clinical, parasitic and immunological. The parasitological diagnosis should be confirmed by the observation of the protozoan in a tissue or smear. Should there be any doubt about the diagnosis, the BMA provides satisfactory results. The differential diagnosis of full-blown VL should include malignant hematological and lymphatic disorders, as well as infectious diseases like malaria. At the present time, the treatment of choice of VL in developed countries is liposomal amphotericin B.

In a review of the literature, it is noteworthy that there are fewer cases of patients with RA being treated with MTX than those receiving anti-tumor necrosis factor (TNF) agents who develop Leishmania infection. We have yet to know why. These patients do not seem to have any common factor predisposing them to infection. Methotrexate reduces the cell immune response, inhibits neutrophil chemotaxis and T-cell proliferation, and has been related to the development of infections by opportunistic pathogens, among which we find Leishmania.

Patients with RA being treated with MTX have a greater predisposition to develop VL than the general population, possibly due to immunological changes related to the underlying disease and the treatment they receive.

Tumor necrosis factor is a cytokine involved in the immune-mediated response to infection, especially against intracellular pathogens. The use of anti-TNF drugs in RA is growing, and their utility is clearly related to an increase in the number of opportunistic infections in these patients.

The diagnosis of VL should be considered in patients when there is a suspicion of infection if they are receiving MTX to treat an inflammatory rheumatic disease and live in regions in which leishmaniasis is endemic.

The importance of the early diagnosis, established during the follow-up visits in relation to the underlying disease, made it possible for us to detect VL in our patient. The prompt initiation of a specific treatment is fundamental in order to improve the prognosis of a potentially serious disease. With this in mind, we must not forget that, although uncommon, leishmaniasis is endemic in the Mediterranean.

Conclusion

The current management of RA patients is very satisfactory.8 Improvements in monitoring and the identification of new therapeutic targets have resulted in high survival rates. The prognosis is likewise more favorable; however, the same therapies that, on occasion, lead to remission, also have certain additional risks.9,10

The present report describes an infectious process that developed in the course of RA, partially due to the associated susceptibility to chronic inflammatory disease, together with the added risk conferred by immunosuppressive therapies like MTX. The study of comorbidities of RA should emphasize infections by the usual pathogens, without overlooking those produced by uncommon opportunistic microorganisms like Leishmania.

Ethical DisclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that no patient data appear in this article.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.

Conflicts of Interest

The authors declare they have no conflicts of interest.

References
[1]
M.E. Weinblatt.
Toxicity of low dose methotrexate in rheumatoid arthritis.
J Rheumatol, 35 (2012), pp. S1985
[2]
G.S. Karagiannidis, M. Mantzourani, J. Meletis, A.N. Anastasopoulou, G.A.J. Vaiopoulos.
Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
J Clin Rheumatol, 18 (2012), pp. 59
[3]
I. Venizelos, Z. Tatsiou, T.G. Papathomas, A. Orazi.
Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
Int J Infect Dis, 13 (2009), pp. 169-172
[4]
A. Català, E. Roé, J. Dalmau, V. Pomar, C. Muñoz, O. Yelamos, et al.
Antitumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature.
Dermatology, 230 (2015), pp. 204-207
[5]
C. Pizzorni, M.E. Secchi, M. Cutolo.
Leishmaniasis in rheumatoid arthritis.
Reumatismo, 59 (2007), pp. 235-239
[6]
K. Michaud, F. Wolfe.
Comorbidities in RA.
Best Pract Res Clin Rheumatol, 21 (2007), pp. 885-906
[7]
Actualización de la Guía de Práctica Clínica para el Manejo de la Artritis Reumatoide en España.
(December 2011),
Available from: http://www.ser.es [accessed 02.05.16]
[8]
J.A. Singh, K.G. Saag, S.L. Bridges Jr., E.A. Akl, R.R. Bannuru, M.C. Sullivan, et al.
2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis.
Arthritis Rheumatol, 68 (2016), pp. 1-26
[9]
J. Gómez Reino, E. Loza, J.L. Andreu, A. Balsa, E. Batlle, J.D. Cañete, et al.
Consenso SER sobre la gestión de riesgo del tratamiento con terapias biológicas en pacientes con enfermedades reumáticas.
Reumatol Clin, 7 (2011), pp. 284-298
[10]
J.S. Richards, S.M. Dowell, M.E. Quinones, G.S. Kerr.
How to use biological agents in patients with rheumatoid arthritis who have comorbid disease.
BMJ, 17 (2015), pp. 351-3658

Please cite this article as: Reina D, Cerdà D, Güell E, Martínez Montauti J, Pineda A, Corominas H. Kala-azar en un paciente con artritis reumatoide tratada con metotrexato. Reumatol Clin. 2017;13:354–356.

Copyright © 2016. Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología
Download PDF
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?